These success, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the thought of concentrating on ACKR3 as a novel strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-linked disorders. Submitting this review implies that https://johng352wmd7.wikirecognition.com/user